Patent n. WO/2011/101787, NON PEPTIDIC 14-3-3 INHIBITORS AND THE USE THEREOF.
Arioli F.; Borrelli S.; Colombo F.; Falchi F.; Filippi I.; Crespan E.; Naldini A.; Scalia G.; Silvani A.; Maga G.; Carraro F.; Botta M.; Passarella D., N-[2-methyl-5-(triazol-1-yl)phenyl]pyrimidin-2-amine as a Scaffold for the synthesis of inhibitors of Bcr-Abl, «CHEMMEDCHEM», 2011, 6, pp. 2009 - 2018 [Scientific article]
Garbelli A.; Radi M.; Falchi F.; Beermann S.; Zanoli S.; Manetti F.; Dietrich U.; Botta M.; Maga G., Targeting the human DEAD-box polypeptide 3 (DDX3) RNA helicase as a novel strategy to inhibit viral replication, «CURRENT MEDICINAL CHEMISTRY», 2011, 18, pp. 3015 - 3027 [Scientific article]
Maga G.; Falchi F.; Radi M.; Botta L.; Casaluce G.; Bernardini M.; Irannejad H.; Manetti F.; Garbelli A.; Samuele A.; Zanoli S.; Este J.A.; Gonzalez E.; Zucca E.; Paolucci S.; Baldanti F.; DeRijck J.; Debyser Z.; Botta M., Toward the Discovery of Novel Anti-HIV Drugs. Second-Generation Inhibitors of the Cellular ATPase DDX3 with Improved Anti-HIV Activity: Synthesis, Structure-Activity Relationship Analysis, Cytotoxicity Studies, and Target Validation, «CHEMMEDCHEM», 2011, 6, pp. 1371 - 1389 [Scientific article]
Radi M.; Crespan E.; Falchi F.; Bernardo V.; Zanoli S.; Manetti F.; Schenone S.; Maga G.; Botta M., Design and synthesis of thiadiazoles and thiazoles targeting the Bcr-Abl T315I mutant: From docking false positives to ATP-noncompetitive inhibitors, «CHEMMEDCHEM», 2010, 5, pp. 1226 - 1231 [Scientific article]
Giovanni Maga, Federico Falchi, Anna Garbelli, Marco Radi, Stefania Paolucci, Fausto Baldanti, Maurizio Botta, Inhibitors of human immunodeficiency virus-1 replication targeting the human DEAD-box polypeptide 3 (DDX3) RNA helicase, «RETROVIROLOGY», 2010, 7, pp. 1 - 1 [Scientific article]
Dreassi E.; Zizzari A.T.; Falchi F.; Schenone S.; Santucci A.; Maga G.; Botta M., Determination of permeability and lipophilicity of pyrazolo-pyrimidine tyrosine kinase inhibitors and correlation with biological data, «EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY», 2009, 44, pp. 3712 - 3717 [Scientific article]
Falchi F.; Manetti F.; Carraro F.; Naldini A.; Maga G.; Crespan E.; Schenone S.; Bruno O.; Brullo C.; Botta M., 3D QSAR models built on structure-based alignments of Abl tyrosine kinase inhibitors, «CHEMMEDCHEM», 2009, 4, pp. 976 - 987 [Scientific article]
Radi M; Crespan E; Botta G; Falchi F; Maga G; Manetti F; Corradi V; Mancini M; Santucci MA; Schenone S; Botta M., Discovery and SAR of 1,3,4-thiadiazole derivatives as potent Abl tyrosine kinase inhibitors and cytodifferentiating agents., «BIOORGANIC & MEDICINAL CHEMISTRY LETTERS», 2008, 18, pp. 1207 - 1211 [Scientific article]
Manetti F.; Falchi F.; Crespan E.; Schenone S.; Maga G.; Botta M., N-(thiazol-2-yl)-2-thiophene carboxamide derivatives as Abl inhibitors identified by a pharmacophore-based database screening of commercially available compounds, «BIOORGANIC & MEDICINAL CHEMISTRY LETTERS», 2008, 18, pp. 4328 - 4331 [Scientific article]
Maga G.; Falchi F.; Garbelli A.; Belfiore A.; Witvrouw M.; Manetti F.; Botta M., Pharmacophore modeling and molecular docking led to the discovery of inhibitors of human immunodeficiency virus-1 replication targeting the human cellular aspartic acid-glutamic acid-alanine-aspartic acid box polypeptide 3, «JOURNAL OF MEDICINAL CHEMISTRY», 2008, 51, pp. 6635 - 6638 [Scientific article]
